Press Release

Global Dry Eye Disease Treatment Market to Grow at a CAGR of 5.7% During 2021-2026, Aided by the Increasing Research and Development (R&D) Activities

Global Dry Eye Disease Treatment Market

According to a new report by EMR titled, ‘Global Dry Eye Disease Treatment Market Report and Forecast 2021-2026’, the market attained a value of about USD 5 billion in 2020. The industry is further expected to grow at a CAGR of 5.7% in the forecast period of 2021-2026 to reach a value of approximately USD 7 billion by 2026.

North America holds a significant share of the overall dry eye disease industry owing to the increasing prevalence of dry eye disease in the region. Moreover, the robust healthcare sector is leading to a surge in the awareness of dry eye disease treatment, which is augmenting the market growth. The increasing research and development (R&D) activities initiated by various companies to develop innovative treatments of dry eye disease are significantly contributing to the industry growth. In addition, the increasing exposure to screens in the United States and Canada is surging the incidents of dry eye disease, which is fuelling the growth of the regional market. Apart from this, the Asia Pacific region is witnessing robust growth owing to the high prevalence of dry eye disease in countries such as Japan, which is augmenting the market growth. In addition, the increasing healthcare accessibility is providing further impetus to the market growth.

AbbVie Inc. (NYSE; ABBV), one of the leading companies in the market, launched REFRESH REPAIR Lubricant Eye Drops, the new over-the-counter (OTC) artificial tear formulation, in July 2018. The product is the first artificial tear in the United States formulated with carboxymethylcellulose (CMC), hydraulic acid, and osmoprotectants. The tears are designed to repair and protect the eyes from the harmful effects of dry eye while improving the clarity of vision. It offers additional options to tailor therapy while adhering to the specific needs of their patients. It also provides improved comfort for patients with dry eye to safeguard the health of epithelial cells and hyperosmotic stress. The development of such products for the treatment of dry eyes is expected to propel the market growth of dry eye disease treatment.

Market Analysis by Product, Distribution Channel, and Region:

  • The market, on the basis of product, can be divided into artificial tears, anti-inflammatory drugs, punctal plugs, and secretagogues, among others.
  • The distribution channels for dry eye disease treatment include hospital pharmacies, independent pharmacies and drug stores, and online pharmacies.
  • The regional markets for dry eye disease treatment include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The wide prevalence of dry eye disease among the growing geriatric population is increasing the demand for its treatment, hence aiding the market growth.
  • The rising smartphone ownership is increasing the prevalence of dry eye disease owing to prolonged exposure to harmful radiation, therefore augmenting the industry growth.
  • The market is being driven by the increasing research and development (R&D) activities initiated by the leading companies to develop novel treatments for dry eye disease.
  • The rising healthcare accessibility in developing countries is surging the demand for the treatment of dry eye disease, which is propelling the industry growth.

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for dry eye disease treatment for the periods (2016-2020) and (2021-2026).
  • The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the products, distribution channels, and regions of dry eye disease treatment.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global dry eye disease treatment market are AbbVie Inc., Bausch and Lomb Incorporated, Johnson & Johnson Services, Inc., Santen Pharmaceutical Co., Ltd, and OASIS Medical, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.